Prediction of significant prostate cancer diagnosed 20 to 30 years later with a single measure of prostate-specific antigen at or before age 50-Reference-Cited by-同舟云学术

Prediction of significant prostate cancer diagnosed 20 to 30 years later with a single measure of prostate-specific antigen at or before age 50

Published:2010-10-19 Issue:6 Volume:117 Page:1210-1219
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Lilja Hans,Cronin Angel M.,Dahlin Anders,Manjer Jonas,Nilsson Peter M.,Eastham James A.,Bjartell Anders S.,Scardino Peter T.,Ulmert David,Vickers Andrew J.

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference31 articles.

1. Screening and prostate-cancer mortality in a randomized European study;Schroder;N Engl J Med.,2009

2. Mortality results from a randomized prostate-cancer screening trial;Andriole;N Engl J Med.,2009

3. Lead times and overdetection due to prostate-specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer;Draisma;J Natl Cancer Inst.,2003

4. Relationship between initial prostate specific antigen level and subsequent prostate cancer detection in a longitudinal screening study;Antenor;J Urol.,2004

5. Low levels of prostate-specific antigen predict long-term risk of prostate cancer: results from the Baltimore Longitudinal Study of Aging;Fang;Urology.,2001

Cited by 122 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prostate-specific antigen screening for prostate cancer: Diagnostic performance, clinical thresholds, and strategies for refinement;Urologic Oncology: Seminars and Original Investigations;2024-07

2. The Role of Baseline Prostate-specific Antigen Value Prior to Age 60 in Predicting Lethal Prostate Cancer: Analysis of a Contemporary North American Cohort;European Urology Oncology;2024-07

3. Treatment of Low-grade Intermediate-risk Nonmuscle-invasive Bladder Cancer With UGN-102 ± Transurethral Resection of Bladder Tumor Compared to Transurethral Resection of Bladder Tumor Monotherapy: A Randomized, Controlled, Phase 3 Trial (ATLAS);Journal of Urology;2023-10

4. Prediction of Overall Survival by Thymidine Kinase 1 Combined with Prostate-Specific Antigen in Men with Prostate Cancer;International Journal of Molecular Sciences;2023-03-08

5. Histopathological results of radical prostatectomy specimen of men younger than 50 years of age at the time of surgery: possible implications for prostate cancer screening programs?;World Journal of Urology;2023-01-19